Evidence map›Paper›PMID 40145046›Full record

ArticleJHLT open2024

Hospital-free days in the first year after lung transplantation and subsequent survival.

Reda E Girgis, Austin Frisch, Cameron K Lawson, Benjamin Kowalske, Lindsey LeQuia, Ryan J Hadley, Sheila Krishnan, Gayathri Sathiyamoorthy, Edward T Murphy

Abstract read
In one paragraph

Article in JHLT open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Reda E GirgisRichard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan.
Austin FrischRichard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan.
Cameron K LawsonRichard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan.
Benjamin KowalskeRichard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan.
Lindsey LeQuiaRichard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan.
Ryan J HadleyRichard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan.
Sheila KrishnanRichard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan.
Gayathri SathiyamoorthyRichard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan.
Edward T MurphyRichard DeVos Heart and Lung Transplant Program, Corewell Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Complications occurring during the first postoperative year after lung transplantation increase the risk of long-term mortality. These events often lead to prolonged and repeated hospitalizations. We sought to assess the relationship between days outside the hospital or hospital-free days (HFD) during the first post-transplant year among 1-year survivors and subsequent retransplant-free survival. Methods: In a single-center study, we derived total inpatient days (initial transplant episode, readmission, and emergency room/observation) from the electronic medical record of lung transplant recipients who survived 1 year. The cohort was divided into HFD quartiles and Kaplan-Meier curves of subsequent transplant-free survival were compared with log-rank analysis. A Cox proportional hazards model was used to test the association of HFD with outcome and adjusted for selected variables. Results: Among 238 patients, 42 deaths and 2 retransplants occurred after a median of 3.6 years post-transplant. The median HFD was 341 (interquartile range: 324, 348). Estimated transplant-free survival at 3 and 5 years post-transplant in the lowest quartile of HFD (79% and 56%, respectively) was considerably worse compared with the first quartile (98% and 94%; Conclusions: HFD during the first year after lung transplantation is a predictor of subsequent long-term outcomes and may be a useful surrogate marker for clinical trials during the early postoperative period.

Indexed as

hospital-free dayslength of hospital staylung transplantreadmissionssurvival

Identifiers

PMID40145046
PMCPMC11935450

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.